As of 4:02pm ET
| +1.38 / +3.90%|
The 19 analysts offering 12-month price forecasts for Imperva Inc have a median target of 60.00, with a high estimate of 77.00 and a low estimate of 34.00. The median estimate represents a +63.35% increase from the last price of 36.73.
The current consensus among 22 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.